Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

432 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Metastasis-suppressor NME1 controls the invasive switch of breast cancer by regulating MT1-MMP surface clearance.
Lodillinsky C, Fuhrmann L, Irondelle M, Pylypenko O, Li XY, Bonsang-Kitzis H, Reyal F, Vacher S, Calmel C, De Wever O, Bièche I, Lacombe ML, Eiján AM, Houdusse A, Vincent-Salomon A, Weiss SJ, Chavrier P, Boissan M. Lodillinsky C, et al. Oncogene. 2021 Jun;40(23):4019-4032. doi: 10.1038/s41388-021-01826-1. Epub 2021 May 19. Oncogene. 2021. PMID: 34012098 Free PMC article.
Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast.
Vincent-Salomon A, Lucchesi C, Gruel N, Raynal V, Pierron G, Goudefroye R, Reyal F, Radvanyi F, Salmon R, Thiery JP, Sastre-Garau X, Sigal-Zafrani B, Fourquet A, Delattre O; breast cancer study group of the Institut Curie. Vincent-Salomon A, et al. Clin Cancer Res. 2008 Apr 1;14(7):1956-65. doi: 10.1158/1078-0432.CCR-07-1465. Clin Cancer Res. 2008. PMID: 18381933
Urokinase-type plasminogen activator and plasminogen-activator-inhibitor type 1 predict metastases in good prognosis breast cancer patients.
De Cremoux P, Grandin L, Diéras V, Savignoni A, Degeorges A, Salmon R, Bollet MA, Reyal F, Sigal-Zafrani B, Vincent-Salomon A, Sastre-Garau X, Magdelénat H, Mignot L, Fourquet A; Breast Cancer Study Group of the Institut Curie. De Cremoux P, et al. Anticancer Res. 2009 May;29(5):1475-82. Anticancer Res. 2009. PMID: 19443353 Free article.
8p22 MTUS1 gene product ATIP3 is a novel anti-mitotic protein underexpressed in invasive breast carcinoma of poor prognosis.
Rodrigues-Ferreira S, Di Tommaso A, Dimitrov A, Cazaubon S, Gruel N, Colasson H, Nicolas A, Chaverot N, Molinié V, Reyal F, Sigal-Zafrani B, Terris B, Delattre O, Radvanyi F, Perez F, Vincent-Salomon A, Nahmias C. Rodrigues-Ferreira S, et al. PLoS One. 2009 Oct 1;4(10):e7239. doi: 10.1371/journal.pone.0007239. PLoS One. 2009. PMID: 19794912 Free PMC article.
A prognostic DNA signature for T1T2 node-negative breast cancer patients.
Gravier E, Pierron G, Vincent-Salomon A, Gruel N, Raynal V, Savignoni A, De Rycke Y, Pierga JY, Lucchesi C, Reyal F, Fourquet A, Roman-Roman S, Radvanyi F, Sastre-Garau X, Asselain B, Delattre O. Gravier E, et al. Genes Chromosomes Cancer. 2010 Dec;49(12):1125-34. doi: 10.1002/gcc.20820. Genes Chromosomes Cancer. 2010. PMID: 20842727
432 results